Trademark: 88522271
Status Date
Monday, February 20, 2023
Filing Date
Thursday, July 18, 2019
Published for Opposition
Tuesday, November 19, 2019
Abandoned Date
Monday, February 20, 2023
5 pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting
Feb 21, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 20, 2023
Abandonment - No Use Statement Filed
Aug 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 9, 2022
Sou Extension 5 Granted
Jul 7, 2022
Sou Extension 5 Filed
Jul 26, 2022
Case Assigned To Intent To Use Paralegal
Jul 7, 2022
Teas Extension Received
Jan 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 7, 2022
Sou Extension 4 Granted
Jan 7, 2022
Sou Extension 4 Filed
Jan 7, 2022
Teas Extension Received
Jul 14, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2021
Sou Extension 3 Granted
Jul 12, 2021
Sou Extension 3 Filed
Jul 12, 2021
Teas Extension Received
Dec 24, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 22, 2020
Sou Extension 2 Granted
Dec 22, 2020
Sou Extension 2 Filed
Dec 22, 2020
Teas Extension Received
Jul 14, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 11, 2020
Sou Extension 1 Granted
Jul 11, 2020
Sou Extension 1 Filed
Jul 11, 2020
Teas Extension Received
Jan 14, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 19, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 19, 2019
Published For Opposition
Oct 30, 2019
Notification Of Notice Of Publication E-Mailed
Oct 15, 2019
Approved For Pub - Principal Register
Oct 5, 2019
Assigned To Examiner
Jul 26, 2019
New Application Office Supplied Data Entered
Jul 22, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
